Correlation Between Novo Nordisk and Q2M Managementberatu

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Q2M Managementberatu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Q2M Managementberatu into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and Q2M Managementberatung AG, you can compare the effects of market volatilities on Novo Nordisk and Q2M Managementberatu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Q2M Managementberatu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Q2M Managementberatu.

Diversification Opportunities for Novo Nordisk and Q2M Managementberatu

0.56

Correlation Coefficient

Novo Nordisk  Q2M Managementberatu

Very weak diversification

The 3 months correlation between Novo and Q2M is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Q2M Managementberatung AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Q2M Managementberatung and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Q2M Managementberatu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Q2M Managementberatung has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Q2M Managementberatu go up and down completely randomly.

Pair Corralation between Novo Nordisk and Q2M Managementberatu

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Q2M Managementberatu. In addition to that, Novo Nordisk is 8.41 times more volatile than Q2M Managementberatung AG. It trades about -0.1 of its total potential returns per unit of risk. Q2M Managementberatung AG is currently generating about -0.18 per unit of volatility. If you would invest  100.00  in Q2M Managementberatung AG on October 1, 2024 and sell it today you would lose (4.00) from holding Q2M Managementberatung AG or give up 4.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Novo Nordisk AS  vs.  Q2M Managementberatung AG

Novo Nordisk AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Q2M Managementberatung

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Q2M Managementberatung AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Q2M Managementberatu is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Novo Nordisk and Q2M Managementberatu

The main advantage of trading using opposite Novo Nordisk and Q2M Managementberatu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Q2M Managementberatu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q2M Managementberatu will offset losses from the drop in Q2M Managementberatu's long position.

The idea behind Novo Nordisk AS and Q2M Managementberatung AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.